Previous 10 | Next 10 |
Doximity press release (NYSE:DOCS): Q4 Non-GAAP EPS of $0.21 beats by $0.06. Revenue of $93.65M (+40.4% Y/Y) beats by $3.48M. Adjusted EBITDA of $39.4 million, versus $26.7 million, an increase of 47% year-over-year, representing adjusted EBITDA margins of 42%, versus 40%. Q1 Outlook: Re...
Doximity Announces Fourth Quarter and Fiscal Year 2022 Financial Results PR Newswire Q4 total revenues of $93.7 million , up 40% year-over-year Q4 net income margin of 39% and adjusted EBITDA margin of 42% Fiscal Year 2022 total revenues of $343...
Biotech is one of the fastest growing areas in healthcare, and one of the more exciting sectors in the stock market. Here's why three Fool.com contributors are bullish on 10x Genomics (NASDAQ: TXG) , Axsome Therapeutics (NASDAQ: AXSM) , and Doximity (NYSE: DOCS) ...
Doximity (NYSE: DOCS) was a popular, new healthcare stock that went public last year. The company, which many call the "LinkedIn for doctors," has focused on making it easier for physicians to connect with their patients and also improve overall workflows. However, the stock has...
Doximity to Release Fiscal 2022 Fourth Quarter Results on May 17, 2022 PR Newswire SAN FRANCISCO , April 26, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy underperformed during a pronounced rotation ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Growth stocks were pressured as the Federal Reserve turne...
Turning $200,000 into $1 million in just 10 years is no easy task, and it requires investments that can handily beat the market over that period. The Nasdaq Composite Index has returned 344% over the past decade, yet even that wouldn't have expanded your money by five times. Beating...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperformed during the quarter due to great...
Multiple waves of digitization have attempted to nudge the healthcare industry forward over the past decades. However, it still largely remains stuck in its old ways. Doximity (NYSE: DOCS), an evolving medical network, is approaching the modernization of healthcare in its own unique way...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...